Eurofins Acquires IDmyk - Molecular Typing for Pharma QC
Eurofins Scientific has acquired IDmyk, a leading laboratory specialized in the areas of detection, identification and molecular typing of microorganisms for the pharmaceutical industry. The acquisition reinforces Eurofins' pharmaceutical quality control offering, and complements its existing capabilities in microbiological analysis.
Since 2000, IDmyk has developed market-leading expertise in establishing the genetic identity of microorganisms to support product or process-related investigations. As such, IDmyk has the largest validated proprietary database for Good Manufacturing Practice (GMP) identification service in the industry. These, combined with Eurofins' existing identification capabilities, strengthen the Group's pharmaceutical QC service offering. Furthermore, rolling-out the methods to the relevant laboratories across the Group network will allow Eurofins to benefit from reduced costs given the use of proprietary reagents in the processes.
Tags: Environmental Monitoring, Genotyping, Sterility Testing, Microbial Strain Typing, Service Laboratory
Date Published: January 17, 2014
Source article link: Eurofins
New Book on Culture Media for Pharmaceutical and Healthcare Manufacturers
EirGenix Inc. Chooses Nova-EM for Automation and Monitoring
Whittlebury Hall Hotel & Spa Chooses Hygiena to Verify Cleanliness
Rapid Micro Biosystems Wins Contract for Rapid Sterility Test for Vaccines